All data are based on the daily closing price as of November 10, 2025
b
Boryung
003850.KO
6.02 USD
0.12
+2.03%
Overview
Last close
6.02 usd
Market cap
508.65M usd
52 week high
9.22 usd
52 week low
5.24 usd
Target price
10.32 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
0.7214
Price/Book Value
0.9279
Enterprise Value
573.02M usd
EV/Revenue
0.8164
EV/EBITDA
9.9028
Key financials
Revenue TTM
701.87M usd
Gross Profit TTM
250.34M usd
EBITDA TTM
77.52M usd
Earnings per Share
N/A usd
Dividend
0.07 usd
Total assets
975.33M usd
Net debt
146.55M usd
About
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.